I also think that a lot of things are being put in
Post# of 157819
Prior to the big Cytodyn Leadership to attend ESMO conference in Germany announcement, we had got news that Leronlimab reversed liver fibrosis and they were going to put together a trial to further demonstrate Leronlimab on fibrosis in other potential organs. That is a really huge deal, but once the ESMO train left the station it has been quiet.
I would think it has been quiet for a reason. I would venture a guess that things are being moved in place with a potential partner or partnerships.
I think everyone is busy working their tales off.
That’s my hope and I’m sticking to it.

